Abbott weathers well "transitional and toughest" quarter of the year
This article was originally published in Clinica
Abbott has posted strong double-digit growth for its first quarter of 2007, allaying concerns that recent developments at the company - such as the sale of its lab diagnostic business to GE Healthcare - may affect its financial performance.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.